Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

CLIPPERS: A case report with radiology, three serial biopsies and a literature review.

Turnquist C, Pretorius PM, DeLuca GC, Halliday J, Kerr R, Hofer M.

Clin Neuropathol. 2020 Jan/Feb;39(1):19-24. doi: 10.5414/NP301219.

PMID:
31661071
2.

A randomised double-blind placebo-controlled feasibility trial of flavonoid-rich cocoa for fatigue in people with relapsing and remitting multiple sclerosis.

Coe S, Cossington J, Collett J, Soundy A, Izadi H, Ovington M, Durkin L, Kirsten M, Clegg M, Cavey A, Wade DT, Palace J, DeLuca GC, Chapman K, Harrison JM, Buckingham E, Dawes H.

J Neurol Neurosurg Psychiatry. 2019 May;90(5):507-513. doi: 10.1136/jnnp-2018-319496. Epub 2019 Mar 4.

PMID:
30833449
3.

Multiple sclerosis and the risk of systemic venous thrombosis: A systematic review.

Ahmed O, Geraldes R, DeLuca GC, Palace J.

Mult Scler Relat Disord. 2019 Jan;27:424-430. doi: 10.1016/j.msard.2018.10.008. Epub 2018 Oct 17. No abstract available.

PMID:
30642566
4.

Rapamycin in ischemic stroke: Old drug, new tricks?

Hadley G, Beard DJ, Couch Y, Neuhaus AA, Adriaanse BA, DeLuca GC, Sutherland BA, Buchan AM.

J Cereb Blood Flow Metab. 2019 Jan;39(1):20-35. doi: 10.1177/0271678X18807309. Epub 2018 Oct 18. Review.

5.

Invited Review: From nose to gut - the role of the microbiome in neurological disease.

Bell JS, Spencer JI, Yates RL, Yee SA, Jacobs BM, DeLuca GC.

Neuropathol Appl Neurobiol. 2019 Apr;45(3):195-215. doi: 10.1111/nan.12520. Epub 2018 Dec 9. Review.

PMID:
30298527
6.

Genes, smoking, and organic solvent exposure: An alarming cocktail for MS risk.

Bell JS, DeLuca GC.

Neurology. 2018 Jul 31;91(5):199-200. doi: 10.1212/WNL.0000000000005896. Epub 2018 Jul 3. No abstract available.

PMID:
29970400
7.

Much, if not all, of the cortical damage in MS can be attributed to the microglial cell - Commentary.

Spencer JI, DeLuca GC.

Mult Scler. 2018 Jun;24(7):899-901. doi: 10.1177/1352458518775549. Epub 2018 May 14. No abstract available.

PMID:
29754502
8.

Contribution of Fibrinogen to Inflammation and Neuronal Density in Human Traumatic Brain Injury.

Jenkins DR, Craner MJ, Esiri MM, DeLuca GC.

J Neurotrauma. 2018 Oct 1;35(19):2259-2271. doi: 10.1089/neu.2017.5291. Epub 2018 Jun 7.

PMID:
29609523
9.

The current role of MRI in differentiating multiple sclerosis from its imaging mimics.

Geraldes R, Ciccarelli O, Barkhof F, De Stefano N, Enzinger C, Filippi M, Hofer M, Paul F, Preziosa P, Rovira A, DeLuca GC, Kappos L, Yousry T, Fazekas F, Frederiksen J, Gasperini C, Sastre-Garriga J, Evangelou N; Jacqueline Palace on behalf of the MAGNIMS study group.

Nat Rev Neurol. 2018 Mar 20;14(4):213. doi: 10.1038/nrneurol.2018.39.

PMID:
29582852
10.

The current role of MRI in differentiating multiple sclerosis from its imaging mimics.

Geraldes R, Ciccarelli O, Barkhof F, De Stefano N, Enzinger C, Filippi M, Hofer M, Paul F, Preziosa P, Rovira A, DeLuca GC, Kappos L, Yousry T, Fazekas F, Frederiksen J, Gasperini C, Sastre-Garriga J, Evangelou N, Palace J; MAGNIMS study group.

Nat Rev Neurol. 2018 Apr;14(4):199-213. doi: 10.1038/nrneurol.2018.14. Epub 2018 Mar 9. Review. Erratum in: Nat Rev Neurol. 2018 Mar 20;14 (4):213.

PMID:
29521337
11.

The cortical blood-brain barrier in multiple sclerosis: a gateway to progression?

Bell JS, Spencer JI, Yates RL, DeLuca GC.

J Neurol. 2018 Apr;265(4):966-967. doi: 10.1007/s00415-017-8727-1. Epub 2018 Feb 13. No abstract available.

PMID:
29442176
12.

Comment: HLA-DRB1*1501 associations with magnetic resonance imaging measures of grey matter pathology in multiple sclerosis.

Yates RL, DeLuca GC.

Mult Scler Relat Disord. 2018 Jan;19:166-167. doi: 10.1016/j.msard.2016.08.005. Epub 2016 Aug 9. No abstract available.

PMID:
29409598
13.

A protocol for a randomised double-blind placebo-controlled feasibility study to determine whether the daily consumption of flavonoid-rich pure cocoa has the potential to reduce fatigue in people with relapsing and remitting multiple sclerosis (RRMS).

Coe S, Collett J, Izadi H, Wade DT, Clegg M, Harrison JM, Buckingham E, Cavey A, DeLuca GC, Palace J, Dawes H.

Pilot Feasibility Stud. 2018 Jan 23;4:35. doi: 10.1186/s40814-018-0230-7. eCollection 2018.

14.

Cortical lesions and HLA genotype: Still a grey area?

Spencer JI, Yates RL, Bell JS, DeLuca GC.

Mult Scler. 2018 May;24(6):818-819. doi: 10.1177/1352458517734071. Epub 2017 Oct 10. No abstract available.

PMID:
28994637
15.

Neurite dispersion: a new marker of multiple sclerosis spinal cord pathology?

Grussu F, Schneider T, Tur C, Yates RL, Tachrount M, Ianuş A, Yiannakas MC, Newcombe J, Zhang H, Alexander DC, DeLuca GC, Gandini Wheeler-Kingshott CAM.

Ann Clin Transl Neurol. 2017 Aug 15;4(9):663-679. doi: 10.1002/acn3.445. eCollection 2017 Sep.

16.

Vascular pathology in multiple sclerosis: reframing pathogenesis around the blood-brain barrier.

Spencer JI, Bell JS, DeLuca GC.

J Neurol Neurosurg Psychiatry. 2018 Jan;89(1):42-52. doi: 10.1136/jnnp-2017-316011. Epub 2017 Aug 31. Review.

PMID:
28860328
17.

The role of the endoplasmic reticulum stress response following cerebral ischemia.

Hadley G, Neuhaus AA, Couch Y, Beard DJ, Adriaanse BA, Vekrellis K, DeLuca GC, Papadakis M, Sutherland BA, Buchan AM.

Int J Stroke. 2018 Jun;13(4):379-390. doi: 10.1177/1747493017724584. Epub 2017 Aug 4.

PMID:
28776456
18.

Fibrin(ogen) and neurodegeneration in the progressive multiple sclerosis cortex.

Yates RL, Esiri MM, Palace J, Jacobs B, Perera R, DeLuca GC.

Ann Neurol. 2017 Aug;82(2):259-270. doi: 10.1002/ana.24997. Epub 2017 Aug 19.

PMID:
28719020
19.

Cultivating the Multiple Sclerosis Workforce of the Future.

DeLuca GC, Buckle G, Cortese I, Graves JS, Halper J, Newsome SD, Sicotte N, Ford CC; FCMSC MS Mentorship Forum Participants.

Int J MS Care. 2017 May-Jun;19(3):123-130. doi: 10.7224/1537-2073.2015-068.

20.

Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease.

Juryńczyk M, Tackley G, Kong Y, Geraldes R, Matthews L, Woodhall M, Waters P, Kuker W, Craner M, Weir A, DeLuca GC, Kremer S, Leite MI, Vincent A, Jacob A, de Sèze J, Palace J.

J Neurol Neurosurg Psychiatry. 2017 Feb;88(2):132-136. doi: 10.1136/jnnp-2016-314005. Epub 2016 Oct 8.

PMID:
27951522
21.

Age-related small vessel disease: a potential contributor to neurodegeneration in multiple sclerosis.

Geraldes R, Esiri MM, DeLuca GC, Palace J.

Brain Pathol. 2017 Nov;27(6):707-722. doi: 10.1111/bpa.12460. Epub 2017 Mar 12. Review.

PMID:
27864848
22.

A framework for optimal whole-sample histological quantification of neurite orientation dispersion in the human spinal cord.

Grussu F, Schneider T, Yates RL, Zhang H, Wheeler-Kingshott CAMG, DeLuca GC, Alexander DC.

J Neurosci Methods. 2016 Nov 1;273:20-32. doi: 10.1016/j.jneumeth.2016.08.002. Epub 2016 Aug 3.

23.

Back on the scent: the olfactory system in CNS demyelinating diseases.

Joseph A, DeLuca GC.

J Neurol Neurosurg Psychiatry. 2016 Oct;87(10):1146-54. doi: 10.1136/jnnp-2015-312600. Epub 2016 Mar 21. Review.

PMID:
27003274
24.

Personalized medical education: Reappraising clinician-scientist training.

DeLuca GC, Ovseiko PV, Buchan AM.

Sci Transl Med. 2016 Jan 13;8(321):321fs2. doi: 10.1126/scitranslmed.aad0689. Review.

PMID:
26764155
25.

The transient intraluminal filament middle cerebral artery occlusion model as a model of endovascular thrombectomy in stroke.

Sutherland BA, Neuhaus AA, Couch Y, Balami JS, DeLuca GC, Hadley G, Harris SL, Grey AN, Buchan AM.

J Cereb Blood Flow Metab. 2016 Feb;36(2):363-9. doi: 10.1177/0271678X15606722. Epub 2015 Oct 2. Review.

26.

Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder.

Nour MM, Nakashima I, Coutinho E, Woodhall M, Sousa F, Revis J, Takai Y, George J, Kitley J, Santos ME, Nour JM, Cheng F, Kuroda H, Misu T, Martins-da-Silva A, DeLuca GC, Vincent A, Palace J, Waters P, Fujihara K, Leite MI.

Neurology. 2016 Jan 5;86(1):79-87. doi: 10.1212/WNL.0000000000002208. Epub 2015 Nov 18.

27.

Loss of galectin-3 decreases the number of immune cells in the subventricular zone and restores proliferation in a viral model of multiple sclerosis.

James RE, Hillis J, Adorján I, Gration B, Mundim MV, Iqbal AJ, Majumdar MM, Yates RL, Richards MM, Goings GE, DeLuca GC, Greaves DR, Miller SD, Szele FG.

Glia. 2016 Jan;64(1):105-21. doi: 10.1002/glia.22906. Epub 2015 Sep 4.

28.

A systematic review and meta-analysis of randomized controlled trials of endovascular thrombectomy compared with best medical treatment for acute ischemic stroke.

Balami JS, Sutherland BA, Edmunds LD, Grunwald IQ, Neuhaus AA, Hadley G, Karbalai H, Metcalf KA, DeLuca GC, Buchan AM.

Int J Stroke. 2015 Dec;10(8):1168-78. doi: 10.1111/ijs.12618. Epub 2015 Aug 26. Review. Erratum in: Int J Stroke. 2017 Jan;12 (1):NP7.

29.

Cognitive impairment in multiple sclerosis: clinical, radiologic and pathologic insights.

DeLuca GC, Yates RL, Beale H, Morrow SA.

Brain Pathol. 2015 Jan;25(1):79-98. doi: 10.1111/bpa.12220. Review.

PMID:
25521179
30.

Olfactory Pathology in Central Nervous System Demyelinating Diseases.

DeLuca GC, Joseph A, George J, Yates RL, Hamard M, Hofer M, Esiri MM.

Brain Pathol. 2015 Sep;25(5):543-51. doi: 10.1111/bpa.12209. Epub 2014 Oct 30.

PMID:
25230202
31.

The influence of HLA-DRB1*15 on motor cortical pathology in multiple sclerosis.

Yates RL, Esiri MM, Palace J, Mittal A, DeLuca GC.

Neuropathol Appl Neurobiol. 2015 Apr;41(3):371-84. doi: 10.1111/nan.12165.

PMID:
24964187
32.

Motor skill learning induces changes in white matter microstructure and myelination.

Sampaio-Baptista C, Khrapitchev AA, Foxley S, Schlagheck T, Scholz J, Jbabdi S, DeLuca GC, Miller KL, Taylor A, Thomas N, Kleim J, Sibson NR, Bannerman D, Johansen-Berg H.

J Neurosci. 2013 Dec 11;33(50):19499-503. doi: 10.1523/JNEUROSCI.3048-13.2013.

33.

TRPV1 gates tissue access and sustains pathogenicity in autoimmune encephalitis.

Paltser G, Liu XJ, Yantha J, Winer S, Tsui H, Wu P, Maezawa Y, Cahill LS, Laliberté CL, Ramagopalan SV, DeLuca GC, Sadovnick AD, Astsaturov I, Ebers GC, Henkelman RM, Salter MW, Dosch HM.

Mol Med. 2013 Jul 24;19:149-59. doi: 10.2119/molmed.2012.00329.

34.

Casting light on multiple sclerosis heterogeneity: the role of HLA-DRB1 on spinal cord pathology.

DeLuca GC, Alterman R, Martin JL, Mittal A, Blundell S, Bird S, Beale H, Hong LS, Esiri MM.

Brain. 2013 Apr;136(Pt 4):1025-34. doi: 10.1093/brain/awt031. Epub 2013 Mar 12.

PMID:
23485854
35.

Early relapses, onset of progression, and late outcome in multiple sclerosis.

Scalfari A, Neuhaus A, Daumer M, Deluca GC, Muraro PA, Ebers GC.

JAMA Neurol. 2013 Feb;70(2):214-22. doi: 10.1001/jamaneurol.2013.599.

PMID:
23407713
36.

Review: the role of vitamin D in nervous system health and disease.

DeLuca GC, Kimball SM, Kolasinski J, Ramagopalan SV, Ebers GC.

Neuropathol Appl Neurobiol. 2013 Aug;39(5):458-84. doi: 10.1111/nan.12020. Review.

PMID:
23336971
37.

A combined post-mortem magnetic resonance imaging and quantitative histological study of multiple sclerosis pathology.

Kolasinski J, Stagg CJ, Chance SA, Deluca GC, Esiri MM, Chang EH, Palace JA, McNab JA, Jenkinson M, Miller KL, Johansen-Berg H.

Brain. 2012 Oct;135(Pt 10):2938-51. doi: 10.1093/brain/aws242.

38.

Seasonal distribution of psychiatric births in England.

Disanto G, Morahan JM, Lacey MV, DeLuca GC, Giovannoni G, Ebers GC, Ramagopalan SV.

PLoS One. 2012;7(4):e34866. doi: 10.1371/journal.pone.0034866. Epub 2012 Apr 4.

39.

Concurrent multiple sclerosis and amyotrophic lateral sclerosis: where inflammation and neurodegeneration meet?

Li G, Esiri MM, Ansorge O, DeLuca GC.

J Neuroinflammation. 2012 Jan 24;9:20. doi: 10.1186/1742-2094-9-20.

40.

Parkinson disease and vitamin D: an interplay between genes and the environment?

DeLuca GC, Li G, Ramagopalan S.

Arch Neurol. 2011 Dec;68(12):1615-6. doi: 10.1001/archneurol.2011.1078. No abstract available.

PMID:
22159068
41.

Vitamin D and multiple sclerosis hospital admissions in Scotland.

Disanto G, Handel AE, Morahan JM, Deluca GC, Kimball SM, Hypponen E, Giovannoni G, Ebers GC, Ramagopalan SV.

QJM. 2011 Nov;104(11):1001-3. doi: 10.1093/qjmed/hcr101. Epub 2011 Jun 29. No abstract available.

42.

Neurologic symptoms and diagnosis in adults with mast cell disease.

Smith JH, Butterfield JH, Pardanani A, DeLuca GC, Cutrer FM.

Clin Neurol Neurosurg. 2011 Sep;113(7):570-4. doi: 10.1016/j.clineuro.2011.05.002. Epub 2011 Jun 12.

PMID:
21664760
43.

Ventral intraspinal fluid-filled collection secondary to CSF leak presenting as bibrachial amyotrophy.

Deluca GC, Boes CJ, Krueger BR, Mokri B, Kumar N.

Neurology. 2011 Apr 19;76(16):1439-40. doi: 10.1212/WNL.0b013e3182166e6f. No abstract available.

PMID:
21502607
44.

Risk alleles for multiple sclerosis in multiplex families.

D'Netto MJ, Ward H, Morrison KM, Ramagopalan SV, Dyment DA, DeLuca GC, Handunnetthi L, Sadovnick AD, Ebers GC.

Neurology. 2009 Jun 9;72(23):1984-8. doi: 10.1212/WNL.0b013e3181a92c25.

PMID:
19506219
45.

Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility.

Lincoln MR, Ramagopalan SV, Chao MJ, Herrera BM, Deluca GC, Orton SM, Dyment DA, Sadovnick AD, Ebers GC.

Proc Natl Acad Sci U S A. 2009 May 5;106(18):7542-7. doi: 10.1073/pnas.0812664106. Epub 2009 Apr 20.

46.

Association of infectious mononucleosis with multiple sclerosis. A population-based study.

Ramagopalan SV, Valdar W, Dyment DA, DeLuca GC, Yee IM, Giovannoni G, Ebers GC, Sadovnick AD; Canadian Collaborative Study Group.

Neuroepidemiology. 2009;32(4):257-62. doi: 10.1159/000201564. Epub 2009 Feb 11.

PMID:
19209005
47.

Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D.

Ramagopalan SV, Maugeri NJ, Handunnetthi L, Lincoln MR, Orton SM, Dyment DA, Deluca GC, Herrera BM, Chao MJ, Sadovnick AD, Ebers GC, Knight JC.

PLoS Genet. 2009 Feb;5(2):e1000369. doi: 10.1371/journal.pgen.1000369. Epub 2009 Feb 6.

48.

Age of puberty and the risk of multiple sclerosis: a population based study.

Ramagopalan SV, Valdar W, Criscuoli M, DeLuca GC, Dyment DA, Orton SM, Yee IM, Ebers GC, Sadovnick AD; Canadian Collaborative Study Group.

Eur J Neurol. 2009 Mar;16(3):342-7. doi: 10.1111/j.1468-1331.2008.02431.x.

PMID:
19170744
49.

Spinal cord neuronal pathology in multiple sclerosis.

Gilmore CP, DeLuca GC, Bö L, Owens T, Lowe J, Esiri MM, Evangelou N.

Brain Pathol. 2009 Oct;19(4):642-9. doi: 10.1111/j.1750-3639.2008.00228.x. Epub 2008 Dec 19.

PMID:
19170682
50.

Mutations in the hemochromatosis gene and the clinical outcome of multiple sclerosis.

Ramagopalan SV, Cukjati M, Cernilec M, DeLuca GC, Dyment DA, Degenhardt A, Sadovnick AD, Serbec VC, Ebers GC, Duquette P.

J Neuroimmunol. 2008 Oct 15;203(1):104-7. doi: 10.1016/j.jneuroim.2008.06.036.

PMID:
18675463

Supplemental Content

Loading ...
Support Center